Multiplex Magnetic Bead Platform
EdgeCode® Multiplex Magnetic Beads
Multiplexed testing is simultaneous on-site detection of different analytes from a single specimen. Recently, it has become more and more important for clinical diagnostics. WinMEMS, a joint venture company with U-GEN, owns the proprietary technology, EdgeCode® Multiplex Magnetic Beads (EMMB). Through the coupling processes, each bead can be tagged with a bio-probe that is used to identify a particular nucleic acid sequence in the case of a molecular assay or a particular protein antigen or antibody in the case of an immunoassay. The unique and patented EMMB is a powerful and efficient coding system allowing to detect up to 4,096 biomarkers for multiplexed testing.
Potential Applications of Multiplex Testing
Through WinMEMS’ state-of-the-art multiplex diagnostic system, more precise, comprehensive, fast and cost-effective IVD testing kits can be developed. This approach can play a crucial role in the pan-cancer screening and clinical diagnosis of multiple tumor biomarkers. Additionally, the platform can also be applied to diagnostics for the detection of animal and plant diseases, food safety, as well as for environmental protection.
Allergen detection
Pathogen detection
Multi-cancer early detection
Companion diagnostics for cancer precision medicine
Infectious disease (sepsis, gastrointestinal, respiratory, neural system)
